CYG
HZNP

Clean Yield Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Clean Yield Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10
Closed -$1K – 488
2022
Q1 		$1K Buy
+10
New +$975 ﹤0.01% 467

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Clean Yield Group's HZNP Position: Q2 2022 in Review

Clean Yield Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2022, closing a stake of 10 shares — an estimated $1K sold.

Clean Yield Group first reported a position in HZNP in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 616 funds tracked by Wall St. Rank hold HZNP as of Q2 2022.

  • Clean Yield Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Clean Yield Group sold 10 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2022, an estimated $1K.
  • Clean Yield Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Clean Yield Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1K in Q1 2022.
  • 616 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2022.

Based on Clean Yield Group's 13F filing for Q2 2022, filed 18 Jul 2022.